{"ticker": "CHRO", "overview": {"cik": "1919246", "ticker": "PTHS", "name": "Pelthos Therapeutics Inc.", "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "sic": "2836", "announcements": [{"form": "10-Q", "date": "2026-08-13", "title": "Quarterly report", "accession": "0001919246-26-000113", "price_sensitive": true}, {"form": "8-K", "date": "2026-08-13", "title": "Material event", "accession": "0001919246-26-000112", "price_sensitive": true}, {"form": "10-Q/A", "date": "2026-08-13", "title": "Form 10-Q/A", "accession": "0001919246-26-000111", "price_sensitive": false}, {"form": "8-K", "date": "2026-08-13", "title": "Material event", "accession": "0001919246-26-000110", "price_sensitive": true}, {"form": "PRE 14A", "date": "2026-08-07", "title": "Form PRE 14A", "accession": "0001919246-26-000105", "price_sensitive": false}, {"form": "4", "date": "2026-07-07", "title": "FORM 4", "accession": "0001919246-26-000102", "price_sensitive": false}, {"form": "4", "date": "2026-07-07", "title": "FORM 4", "accession": "0001919246-26-000101", "price_sensitive": false}, {"form": "4", "date": "2026-07-07", "title": "FORM 4", "accession": "0001919246-26-000100", "price_sensitive": false}, {"form": "4", "date": "2026-06-17", "title": "FORM 4", "accession": "0001919246-26-000093", "price_sensitive": false}, {"form": "4", "date": "2026-06-15", "title": "FORM 4", "accession": "0001919246-26-000088", "price_sensitive": false}, {"form": "8-K", "date": "2026-05-28", "title": "Material event", "accession": "0001919246-26-000085", "price_sensitive": true}, {"form": "4", "date": "2026-05-26", "title": "FORM 4", "accession": "0001919246-26-000081", "price_sensitive": false}, {"form": "144", "date": "2026-05-22", "title": "Notice of proposed sale", "accession": "0001959173-26-003914", "price_sensitive": false}, {"form": "8-K", "date": "2026-05-21", "title": "Material event", "accession": "0001919246-26-000078", "price_sensitive": true}, {"form": "4", "date": "2026-05-18", "title": "FORM 4", "accession": "0001919246-26-000073", "price_sensitive": false}, {"form": "SCHEDULE 13G/A", "date": "2026-05-15", "title": "Form SCHEDULE 13G/A", "accession": "0001193125-26-227121", "price_sensitive": false}, {"form": "8-K", "date": "2026-05-14", "title": "Material event", "accession": "0001919246-26-000071", "price_sensitive": true}, {"form": "10-Q", "date": "2026-05-14", "title": "Quarterly report", "accession": "0001919246-26-000070", "price_sensitive": true}, {"form": "SCHEDULE 13G/A", "date": "2026-05-07", "title": "Form SCHEDULE 13G/A", "accession": "0001753926-26-000789", "price_sensitive": false}, {"form": "3", "date": "2026-04-20", "title": "FORM 3", "accession": "0001919246-26-000063", "price_sensitive": false}, {"form": "8-K", "date": "2026-04-14", "title": "Material event", "accession": "0001919246-26-000060", "price_sensitive": true}, {"form": "8-K", "date": "2026-04-10", "title": "Material event", "accession": "0001919246-26-000058", "price_sensitive": true}, {"form": "4", "date": "2026-04-06", "title": "FORM 4", "accession": "0001919246-26-000055", "price_sensitive": false}, {"form": "4", "date": "2026-04-06", "title": "FORM 4", "accession": "0001919246-26-000054", "price_sensitive": false}, {"form": "4", "date": "2026-04-06", "title": "FORM 4", "accession": "0001919246-26-000053", "price_sensitive": false}]}, "description": "", "exchange": null, "stats": {"buy_n": 4, "buy_sum": 125825.88, "sell_n": 0, "sell_sum": 0, "net": 125825.88, "insiders": 3, "first_date": "2024-02-21", "last_date": "2024-09-13"}, "metrics": {"ticker": "CHRO", "has_prices": false}, "trades": [{"id": "0001753926-25-000643", "src": "INSIDERS", "ticker": "CHRO", "cik": "1919246", "company": "Pelthos Therapeutics Inc.", "company_raw": "Channel Therapeutics Corp", "who": "Knuettel Francis II", "who_key": "Francis Knuettel II", "role": "CEO, Pres., CFO, Treas & Secty", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CEO files routine paperwork on CHRO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1919246/000175392625000643/0001753926-25-000643-index.htm", "trade_date": "2025-04-11", "timestamp": "2025-04-11", "mins": 821683}, {"id": "0001753926-25-000644", "src": "INSIDERS", "ticker": "CHRO", "cik": "1919246", "company": "Pelthos Therapeutics Inc.", "company_raw": "Channel Therapeutics Corp", "who": "Chia-Lin Simmons", "who_key": "Simmons Chia-Lin", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on CHRO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1919246/000175392625000644/0001753926-25-000644-index.htm", "trade_date": "2025-04-11", "timestamp": "2025-04-11", "mins": 821683}, {"id": "0001753926-24-001947", "src": "INSIDERS", "ticker": "CHRO", "cik": "1919246", "company": "Pelthos Therapeutics Inc.", "company_raw": "Chromocell Therapeutics Corp", "who": "Ezra M. Friedberg", "who_key": "Friedberg Ezra M", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on CHRO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1919246/000175392624001947/0001753926-24-001947-index.htm", "trade_date": "2024-11-13", "timestamp": "2024-11-13", "mins": 1036243}, {"id": "0001753926-24-001949", "src": "INSIDERS", "ticker": "CHRO", "cik": "1919246", "company": "Pelthos Therapeutics Inc.", "company_raw": "Chromocell Therapeutics Corp", "who": "Richard Malamut", "who_key": "Malamut Richard", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on CHRO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1919246/000175392624001949/0001753926-24-001949-index.htm", "trade_date": "2024-11-13", "timestamp": "2024-11-13", "mins": 1036243}, {"id": "0001753926-24-001951", "src": "INSIDERS", "ticker": "CHRO", "cik": "1919246", "company": "Pelthos Therapeutics Inc.", "company_raw": "Chromocell Therapeutics Corp", "who": "Todd C. Davis", "who_key": "Davis Todd C", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on CHRO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1919246/000175392624001951/0001753926-24-001951-index.htm", "trade_date": "2024-11-13", "timestamp": "2024-11-13", "mins": 1036243}, {"id": "0001753926-24-001576", "src": "INSIDERS", "ticker": "CHRO", "cik": "1919246", "company": "Pelthos Therapeutics Inc.", "company_raw": "Chromocell Therapeutics Corp", "who": "Knuettel Francis II", "who_key": "Francis Knuettel II", "role": "CEO, Pres., CFO, Treas & Secty", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 5044.0, "score": 34.5, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Chief exec picks up $5K of CHRO", "source_url": "https://www.sec.gov/Archives/edgar/data/1919246/000175392624001576/0001753926-24-001576-index.htm", "trade_date": "2024-09-13", "timestamp": "2024-09-13", "mins": 1124083}, {"id": "0001753926-24-001578", "src": "INSIDERS", "ticker": "CHRO", "cik": "1919246", "company": "Pelthos Therapeutics Inc.", "company_raw": "Chromocell Therapeutics Corp", "who": "Richard Malamut", "who_key": "Malamut Richard", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 9824.88, "score": 29.3, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CHRO lands a director's $10K", "source_url": "https://www.sec.gov/Archives/edgar/data/1919246/000175392624001578/0001753926-24-001578-index.htm", "trade_date": "2024-09-12", "timestamp": "2024-09-12", "mins": 1125523}, {"id": "0001753926-24-001570", "src": "INSIDERS", "ticker": "CHRO", "cik": "1919246", "company": "Pelthos Therapeutics Inc.", "company_raw": "Chromocell Therapeutics Corp", "who": "Knuettel Francis II", "who_key": "Francis Knuettel II", "role": "CEO, Pres., CFO, Treas & Secty", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 10955.0, "score": 38.1, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CHRO draws its 3th insider buyer", "source_url": "https://www.sec.gov/Archives/edgar/data/1919246/000175392624001570/0001753926-24-001570-index.htm", "trade_date": "2024-09-11", "timestamp": "2024-09-11", "mins": 1126963}, {"id": "0001753926-24-001211", "src": "INSIDERS", "ticker": "CHRO", "cik": "1919246", "company": "Pelthos Therapeutics Inc.", "company_raw": "Chromocell Therapeutics Corp", "who": "Knuettel Francis II", "who_key": "Francis Knuettel II", "role": "CEO, Pres., CFO Treas & Secty", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CEO files routine paperwork on CHRO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1919246/000175392624001211/0001753926-24-001211-index.htm", "trade_date": "2024-06-28", "timestamp": "2024-06-28", "mins": 1234963}, {"id": "0001753926-24-001127", "src": "INSIDERS", "ticker": "CHRO", "cik": "1919246", "company": "Pelthos Therapeutics Inc.", "company_raw": "Chromocell Therapeutics Corp", "who": "Todd C. Davis", "who_key": "Davis Todd C", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on CHRO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1919246/000175392624001127/0001753926-24-001127-index.htm", "trade_date": "2024-06-14", "timestamp": "2024-06-14", "mins": 1255123}, {"id": "0001753926-24-001129", "src": "INSIDERS", "ticker": "CHRO", "cik": "1919246", "company": "Pelthos Therapeutics Inc.", "company_raw": "Chromocell Therapeutics Corp", "who": "Knuettel Francis II", "who_key": "Francis Knuettel II", "role": "CEO, Pres., CFO Treas & Secty", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CEO files routine paperwork on CHRO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1919246/000175392624001129/0001753926-24-001129-index.htm", "trade_date": "2024-06-14", "timestamp": "2024-06-14", "mins": 1255123}, {"id": "0001753926-24-001131", "src": "INSIDERS", "ticker": "CHRO", "cik": "1919246", "company": "Pelthos Therapeutics Inc.", "company_raw": "Chromocell Therapeutics Corp", "who": "Richard Malamut", "who_key": "Malamut Richard", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on CHRO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1919246/000175392624001131/0001753926-24-001131-index.htm", "trade_date": "2024-06-14", "timestamp": "2024-06-14", "mins": 1255123}, {"id": "0001753926-24-001133", "src": "INSIDERS", "ticker": "CHRO", "cik": "1919246", "company": "Pelthos Therapeutics Inc.", "company_raw": "Chromocell Therapeutics Corp", "who": "Ezra M. Friedberg", "who_key": "Friedberg Ezra M", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on CHRO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1919246/000175392624001133/0001753926-24-001133-index.htm", "trade_date": "2024-06-14", "timestamp": "2024-06-14", "mins": 1255123}, {"id": "0001753926-24-001135", "src": "INSIDERS", "ticker": "CHRO", "cik": "1919246", "company": "Pelthos Therapeutics Inc.", "company_raw": "Chromocell Therapeutics Corp", "who": "Eric Lang", "who_key": "Lang Eric", "role": "Chief Medical Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite exec files routine paperwork on CHRO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1919246/000175392624001135/0001753926-24-001135-index.htm", "trade_date": "2024-06-14", "timestamp": "2024-06-14", "mins": 1255123}, {"id": "0001753926-24-001137", "src": "INSIDERS", "ticker": "CHRO", "cik": "1919246", "company": "Pelthos Therapeutics Inc.", "company_raw": "Chromocell Therapeutics Corp", "who": "Chia-Lin Simmons", "who_key": "Simmons Chia-Lin", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on CHRO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1919246/000175392624001137/0001753926-24-001137-index.htm", "trade_date": "2024-06-14", "timestamp": "2024-06-14", "mins": 1255123}, {"id": "0001753926-24-000372", "src": "INSIDERS", "ticker": "CHRO", "cik": "1919246", "company": "Pelthos Therapeutics Inc.", "company_raw": "Chromocell Therapeutics Corp", "who": "Ezra M. Friedberg", "who_key": "Friedberg Ezra M", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 99076.79999999999, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on CHRO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1919246/000175392624000372/0001753926-24-000372-index.htm", "trade_date": "2024-02-21", "timestamp": "2024-02-21", "mins": 1419283}, {"id": "0001753926-24-000374", "src": "INSIDERS", "ticker": "CHRO", "cik": "1919246", "company": "Pelthos Therapeutics Inc.", "company_raw": "Chromocell Therapeutics Corp", "who": "Todd C. Davis", "who_key": "Davis Todd C", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 140001.6, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on CHRO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1919246/000175392624000374/0001753926-24-000374-index.htm", "trade_date": "2024-02-21", "timestamp": "2024-02-21", "mins": 1419283}, {"id": "0001753926-24-000376", "src": "INSIDERS", "ticker": "CHRO", "cik": "1919246", "company": "Pelthos Therapeutics Inc.", "company_raw": "Chromocell Therapeutics Corp", "who": "Knuettel Francis II", "who_key": "Francis Knuettel II", "role": "Interim CEO, CFO Treas & Secty", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CEO files routine paperwork on CHRO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1919246/000175392624000376/0001753926-24-000376-index.htm", "trade_date": "2024-02-21", "timestamp": "2024-02-21", "mins": 1419283}, {"id": "0001753926-24-000518", "src": "INSIDERS", "ticker": "CHRO", "cik": "1919246", "company": "Pelthos Therapeutics Inc.", "company_raw": "Chromocell Therapeutics Corp", "who": "Ezra M. Friedberg", "who_key": "Friedberg Ezra M", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 100002.0, "score": 39.5, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "That makes 3 insiders into CHRO", "source_url": "https://www.sec.gov/Archives/edgar/data/1919246/000175392624000518/0001753926-24-000518-index.htm", "trade_date": "2024-02-21", "timestamp": "2024-02-21", "mins": 1419283}, {"id": "0001753926-24-001139", "src": "INSIDERS", "ticker": "CHRO", "cik": "1919246", "company": "Pelthos Therapeutics Inc.", "company_raw": "Chromocell Therapeutics Corp", "who": "Knuettel Francis II", "who_key": "Francis Knuettel II", "role": "CEO, Pres., CFO Treas & Secty", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CEO files routine paperwork on CHRO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1919246/000175392624001139/0001753926-24-001139-index.htm", "trade_date": "2024-02-21", "timestamp": "2024-02-21", "mins": 1419283}], "recent_buys": [{"id": "0001753926-24-001576", "src": "INSIDERS", "ticker": "CHRO", "cik": "1919246", "company": "Pelthos Therapeutics Inc.", "company_raw": "Chromocell Therapeutics Corp", "who": "Knuettel Francis II", "who_key": "Francis Knuettel II", "role": "CEO, Pres., CFO, Treas & Secty", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 5044.0, "score": 34.5, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Chief exec picks up $5K of CHRO", "source_url": "https://www.sec.gov/Archives/edgar/data/1919246/000175392624001576/0001753926-24-001576-index.htm", "trade_date": "2024-09-13", "timestamp": "2024-09-13", "mins": 1124083}, {"id": "0001753926-24-001578", "src": "INSIDERS", "ticker": "CHRO", "cik": "1919246", "company": "Pelthos Therapeutics Inc.", "company_raw": "Chromocell Therapeutics Corp", "who": "Richard Malamut", "who_key": "Malamut Richard", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 9824.88, "score": 29.3, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CHRO lands a director's $10K", "source_url": "https://www.sec.gov/Archives/edgar/data/1919246/000175392624001578/0001753926-24-001578-index.htm", "trade_date": "2024-09-12", "timestamp": "2024-09-12", "mins": 1125523}, {"id": "0001753926-24-001570", "src": "INSIDERS", "ticker": "CHRO", "cik": "1919246", "company": "Pelthos Therapeutics Inc.", "company_raw": "Chromocell Therapeutics Corp", "who": "Knuettel Francis II", "who_key": "Francis Knuettel II", "role": "CEO, Pres., CFO, Treas & Secty", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 10955.0, "score": 38.1, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CHRO draws its 3th insider buyer", "source_url": "https://www.sec.gov/Archives/edgar/data/1919246/000175392624001570/0001753926-24-001570-index.htm", "trade_date": "2024-09-11", "timestamp": "2024-09-11", "mins": 1126963}, {"id": "0001753926-24-000518", "src": "INSIDERS", "ticker": "CHRO", "cik": "1919246", "company": "Pelthos Therapeutics Inc.", "company_raw": "Chromocell Therapeutics Corp", "who": "Ezra M. Friedberg", "who_key": "Friedberg Ezra M", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 100002.0, "score": 39.5, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "That makes 3 insiders into CHRO", "source_url": "https://www.sec.gov/Archives/edgar/data/1919246/000175392624000518/0001753926-24-000518-index.htm", "trade_date": "2024-02-21", "timestamp": "2024-02-21", "mins": 1419283}], "institutional": [], "holdings": [], "directors": [], "status": {"status": "delisted", "exchange": null, "note": "No longer in the live ASX listing \u2014 delisted, acquired or merged. Historical filings are retained here; live price history ends at delisting."}, "corporate_actions": {"status_label": "", "items": []}, "key_people": [{"who": "Ezra M. Friedberg", "who_key": "Friedberg Ezra M", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 100002.0, "sold": 0, "net": 100002.0, "trades": 1, "top_score": 39.5, "lean": "buying", "history": [{"action": "BUY", "amount": 100002.0, "date": "2024-02-21", "score": 39.5, "source_url": "https://www.sec.gov/Archives/edgar/data/1919246/000175392624000518/0001753926-24-000518-index.htm"}], "latest": {"action": "BUY", "amount": 100002.0, "date": "2024-02-21", "score": 39.5, "source_url": "https://www.sec.gov/Archives/edgar/data/1919246/000175392624000518/0001753926-24-000518-index.htm"}}, {"who": "Knuettel Francis II", "who_key": "Francis Knuettel II", "role": "CEO, Pres., CFO, Treas & Secty", "person_type": "C_SUITE", "person_label": "C-Suite", "bought": 15999.0, "sold": 0, "net": 15999.0, "trades": 2, "top_score": 38.1, "lean": "buying", "history": [{"action": "BUY", "amount": 5044.0, "date": "2024-09-13", "score": 34.5, "source_url": "https://www.sec.gov/Archives/edgar/data/1919246/000175392624001576/0001753926-24-001576-index.htm"}, {"action": "BUY", "amount": 10955.0, "date": "2024-09-11", "score": 38.1, "source_url": "https://www.sec.gov/Archives/edgar/data/1919246/000175392624001570/0001753926-24-001570-index.htm"}], "latest": {"action": "BUY", "amount": 5044.0, "date": "2024-09-13", "score": 34.5, "source_url": "https://www.sec.gov/Archives/edgar/data/1919246/000175392624001576/0001753926-24-001576-index.htm"}}, {"who": "Richard Malamut", "who_key": "Malamut Richard", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 9824.88, "sold": 0, "net": 9824.88, "trades": 1, "top_score": 29.3, "lean": "buying", "history": [{"action": "BUY", "amount": 9824.88, "date": "2024-09-12", "score": 29.3, "source_url": "https://www.sec.gov/Archives/edgar/data/1919246/000175392624001578/0001753926-24-001578-index.htm"}], "latest": {"action": "BUY", "amount": 9824.88, "date": "2024-09-12", "score": 29.3, "source_url": "https://www.sec.gov/Archives/edgar/data/1919246/000175392624001578/0001753926-24-001578-index.htm"}}], "activity": [], "announcements": [{"form": "10-Q", "date": "2026-08-13", "title": "Quarterly report", "accession": "0001919246-26-000113", "price_sensitive": true}, {"form": "8-K", "date": "2026-08-13", "title": "Material event", "accession": "0001919246-26-000112", "price_sensitive": true}, {"form": "10-Q/A", "date": "2026-08-13", "title": "Form 10-Q/A", "accession": "0001919246-26-000111", "price_sensitive": false}, {"form": "8-K", "date": "2026-08-13", "title": "Material event", "accession": "0001919246-26-000110", "price_sensitive": true}, {"form": "PRE 14A", "date": "2026-08-07", "title": "Form PRE 14A", "accession": "0001919246-26-000105", "price_sensitive": false}, {"form": "4", "date": "2026-07-07", "title": "FORM 4", "accession": "0001919246-26-000102", "price_sensitive": false}, {"form": "4", "date": "2026-07-07", "title": "FORM 4", "accession": "0001919246-26-000101", "price_sensitive": false}, {"form": "4", "date": "2026-07-07", "title": "FORM 4", "accession": "0001919246-26-000100", "price_sensitive": false}, {"form": "4", "date": "2026-06-17", "title": "FORM 4", "accession": "0001919246-26-000093", "price_sensitive": false}, {"form": "4", "date": "2026-06-15", "title": "FORM 4", "accession": "0001919246-26-000088", "price_sensitive": false}, {"form": "8-K", "date": "2026-05-28", "title": "Material event", "accession": "0001919246-26-000085", "price_sensitive": true}, {"form": "4", "date": "2026-05-26", "title": "FORM 4", "accession": "0001919246-26-000081", "price_sensitive": false}, {"form": "144", "date": "2026-05-22", "title": "Notice of proposed sale", "accession": "0001959173-26-003914", "price_sensitive": false}, {"form": "8-K", "date": "2026-05-21", "title": "Material event", "accession": "0001919246-26-000078", "price_sensitive": true}, {"form": "4", "date": "2026-05-18", "title": "FORM 4", "accession": "0001919246-26-000073", "price_sensitive": false}, {"form": "SCHEDULE 13G/A", "date": "2026-05-15", "title": "Form SCHEDULE 13G/A", "accession": "0001193125-26-227121", "price_sensitive": false}, {"form": "8-K", "date": "2026-05-14", "title": "Material event", "accession": "0001919246-26-000071", "price_sensitive": true}, {"form": "10-Q", "date": "2026-05-14", "title": "Quarterly report", "accession": "0001919246-26-000070", "price_sensitive": true}, {"form": "SCHEDULE 13G/A", "date": "2026-05-07", "title": "Form SCHEDULE 13G/A", "accession": "0001753926-26-000789", "price_sensitive": false}, {"form": "3", "date": "2026-04-20", "title": "FORM 3", "accession": "0001919246-26-000063", "price_sensitive": false}, {"form": "8-K", "date": "2026-04-14", "title": "Material event", "accession": "0001919246-26-000060", "price_sensitive": true}, {"form": "8-K", "date": "2026-04-10", "title": "Material event", "accession": "0001919246-26-000058", "price_sensitive": true}, {"form": "4", "date": "2026-04-06", "title": "FORM 4", "accession": "0001919246-26-000055", "price_sensitive": false}, {"form": "4", "date": "2026-04-06", "title": "FORM 4", "accession": "0001919246-26-000054", "price_sensitive": false}, {"form": "4", "date": "2026-04-06", "title": "FORM 4", "accession": "0001919246-26-000053", "price_sensitive": false}], "performance": {"ticker": "CHRO", "has_prices": false, "summary": null, "buys": [{"who": "Francis Knuettel II", "person_type": "C_SUITE", "person_label": "C-Suite", "role": "CEO, Pres., CFO, Treas & Secty", "amount": 5044.0, "date": "2024-09-13", "score": 34.5, "ref_price": null, "return": null}, {"who": "Malamut Richard", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 9824.88, "date": "2024-09-12", "score": 29.3, "ref_price": null, "return": null}, {"who": "Francis Knuettel II", "person_type": "C_SUITE", "person_label": "C-Suite", "role": "CEO, Pres., CFO, Treas & Secty", "amount": 10955.0, "date": "2024-09-11", "score": 38.1, "ref_price": null, "return": null}, {"who": "Friedberg Ezra M", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 100002.0, "date": "2024-02-21", "score": 39.5, "ref_price": null, "return": null}]}, "price_series": [], "refreshing": true}